Actelion gets go-ahead to continue new drug trial
ZURICH (Reuters) - Actelion should continue a late-stage study into a new heart and lung drug, independent monitors have recommended, with final resul...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/14YA10NiU4E/story01.htm
No comments:
Post a Comment